Patients | Keeping pharma's end user at the centre

Patients

pharmaphorum podcast Episode 234, Amy Bucher, Lirio

Delivering the right behavioural ingredients for the moment,...

Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.

News

DBV gets peanut allergy therapy programme back on track

Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.

News

Acting CDC director and former tech investor Jim O'Neill

CDC signs off on advice ending universal hepatitis B jabs

Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.

News

Prof Jonathan Benger named as NICE's new CEO

Prof Jonathan Benger will take over from Dr Sam Roberts as CEO of UK reimbursement authority NICE later this week, at a critical time for the agency.

News

Kyverna rises on stiff person syndrome data

Kyverna hopes to file CAR-T therapy miv-cell for approval as the first therapy for stiff person syndrome, a rare and debilitating autoimmune disease.

Patients

Digitisation is fundamental to unlocking a patient-centric i...

The fallout of the pandemic coupled with economic uncertainty has left the life sciences and healthcare sectors more stretched than ever, from pharmaceutical manufacturers to healthcare pra

News

Five takeaways from the new donanemab data

Headlines about the results of TRAILBLAZER-ALZ2 trial of Eli Lilly’s Alzheimer’s drug candidate donanemab are spreading around the world, with some going as far as to sugg

News

Akili says ADHD game works in adults too

Akili Interactive has revealed the findings of a trial of its digital therapeutic (DTx) for attention-deficit hyperactivity disorder (ADHD) in adults, suggesting it may be

News

DBV gets peanut allergy therapy programme back on track

Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.

News

CDC signs off on advice ending universal hepatitis B jabs

Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.

Press Releases

Digital

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Partner Content

Partner Content

The RARE Youth Revolution has begun

RARE Revolution Magazine proudly launches dedicated RARE youth online platform

Views & Analysis

Patients

Delivering the right behavioural ingredients for the moment,...

Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.

Patients

pharmaphorum podcast Episode 228, Ruth Chambers, Raparu Consult CIC

The NHS, system burden, and a transformation prescription, w...

Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.

Deep Dive

Patients

How to land a deal with big pharma

Patients

When drug prices collide: How US policy shifts are hitting p...

Patients

What’s powering the next wave of life sciences investment in...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Patients

Sponsored

Unlocking the Power of Storytelling in Medical Publications

In this era of accelerating information, it is more critical than ever to be clear and engaging in medical publications – and that increasingly involves the skill of scientific storytelling

Patients

Sponsored

Voices to Trials: Engaging Patients in Clinical Trial Design

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Podcasts

Patients

Delivering the right behavioural ingredients for the moment,...

Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.

Patients

The NHS, system burden, and a transformation prescription, w...

Dr Ruth Chambers OBE, co-director of Raparu Consult CIC and a visiting professor at Staffordshire University, discusses her book on the NHS.

Patients

Frontiers Health limited series podcast, Roberta Sarno

FH25: On patient access and equity, with Roberta Sarno

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.

Video

Patients

Where Patients Lead: Insights from Frontiers Health 2025

At Frontiers Health 2025, patient advocate Silvia Cerolini (Eyes on the Future) opened the conference by sharing her story.

Patients

Jonah Comstock at AAPS interviewing Mehul Desai

Challenging conventional wisdom on injectables, with Mehul D...

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

Patients

Reuters pharma USA 2025 Faruk Abdullah interview

Direct-to-patient is more than just telehealth – with EVERSA...

Hear from EVERSANA's Faruk Abdullah in this video interview as he explains why direct-to-patient strategies go beyond telehealth.

White Papers

Oncology

Sponsored

Patient Centricity to Integration: Enhancing Cancer Outcomes

We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.

Debates & Insight

Sponsored

An integrated digital ecosystem to support patient outcomes,...

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world

Debates & Insight

Sponsored

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity is a subject that is massively talked about but few can 'walk the talk'.

Event

Patients

Partner Content

Operationalize: Expanded Access Programs comes to the West C...

Improving Global Access to Life-Changing Therapeutics...

Patients

Reuters Pharma Barcelona 2023

The Reuters Pharma 2023 event is live in Barcelona and pharmaphorum is on site to provide readers with rolling coverage of the speakers and concepts as unfolds over the next few days.

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Views & Analysis

Words, inclusivity, and the struggle for health equality

Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.

Views & Analysis

Sponsored

Understanding blockchain – a practical guide for life scienc...

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b

Partner Content

Patients

Partner Content

Patient Recruitment for Rare Disease Trials Summit

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.

Patients

Partner Content

How walking in a patient's shoes adds value to your patient ...

Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?

Patients

Partner Content

The PM Society – Giving Back

The PM Society is a not-for-profit organisation with 40 years of Giving Back.

News

Press Releases

Views & Analysis

Editor's Picks

Deep Dive

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content

Editor's Picks